इंटेलिजेंस रिपोर्ट

Science Corporation secures $400m Series D to widen PRIMA retinal implant rollout

The brain-computer interface company led by Neuralink co-founder Max Hodak will fund European expansion of its vision implant and prepare for a US launch.

INSIGHTEX Editorial Desk

पढ़ने में 2 मिनट

Science Corporation secures $400m Series D to widen PRIMA retinal implant rolloutइंटेलिजेंस रिपोर्ट

What happened

Brain-computer interface developer Science Corporation has closed a $400m Series D, the US company announced in a blog post on Tuesday, TNW | Deep-tech reported. Backers include Y Combinator, Khosla Ventures, PLC Neurotech, Tenet Healthcare, 885 Capital and the Ackman Oxman Institute, alongside other investors. The company did not identify a lead investor and did not say what the round values it at.

The new capital is earmarked for broadening access to PRIMA, the company's retinal implant, across Europe and for groundwork ahead of a US launch. Science intends to pursue FDA approval via the Humanitarian Device Exemption, a route meant for devices serving small patient populations. Remaining funds will go to research, manufacturing and a biohybrid brain interface that relies on lab-grown neurons to connect electronics with the brain.

The raise lifts Science's total funding past $900m since its founding in 2021. It comes eight months after a $230m Series C, a round that was reported at the time to value the company at $1.5bn. Science is led by Max Hodak, a Neuralink co-founder who previously served as that company's president.

Context

PRIMA is a chip placed beneath the retina that operates together with camera glasses, aimed at people whose central vision has been lost to geographic atrophy, an advanced stage of dry age-related macular degeneration. It obtained a CE mark in July, permitting sales in 30 European countries, and Science says it is the first brain-computer interface carrying that mark to restore form vision, meaning reading letters, numbers and words.

Khosla Ventures profile

स्रोतTNW | Deep-tech

ब्रीफ़िंग

टेक का पूरा सप्ताह, एक ईमेल में।

हर सप्ताह वे रिपोर्ट्स जो आपके समय के लायक हैं। कभी भी अनसब्सक्राइब करें।